Integrative multi-omics analysis identifies SNRPE as a key driver gene in Uterine corpus endometrial carcinoma: promoting tumor progression, and mediating immune evasion - Top-Institutions - MDSpire

Integrative multi-omics analysis identifies SNRPE as a key driver gene in Uterine corpus endometrial carcinoma: promoting tumor progression, and mediating immune evasion

  • By

  • Cao, Minyue

  • Ding, Yan

  • Kang, Luyao

  • Zhang, Yiqin

  • Jiang, Genyi

  • Yan, Jiayu

  • Sun, Yihan

  • Zhang, Yanli

  • Luo, Jing

  • Zhou, Xue

  • Wu, Hanyong

  • Li, Bilan

  • May 6, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology
    • Gynecologic Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology
    • Gynecologic Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Cancer Research

  • #4

    National Human Genome Research Institute
    National Human Genome Research Institute

    Bethesda, Maryland

    Key Differentiators

    • Genomics
    • Oncology

  • #5

    Johns Hopkins Medical Institutions
    Johns Hopkins Medical Institutions

    Baltimore, Maryland

    Key Differentiators

    • Oncology
    • Gynecologic Oncology

Original Source(s)

Integrative multi-omics analysis identifies SNRPE as a key driver gene in Uterine corpus endometrial carcinoma: promoting tumor progression, and mediating immune evasion

  • by Cao, Minyue , Ding, Yan , Kang, Luyao , Zhang, Yiqin , Jiang, Genyi , Yan, Jiayu , Sun, Yihan , Zhang, Yanli , Luo, Jing , Zhou, Xue , Wu, Hanyong , Li, Bilan

  • May 6, 2026

Related Content

Data requirements of an informative, directive, and preventive mobile health application for gastric cancer

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”

Biotech exec Jeremy Levin on the industry’s strategic turning point